Senior Director, Medicine Development Leader

Das ist der Job

Our employees come from a variety of backgrounds within research, healthcare, industry and the academic sphere.

Darum lohnt es sich

Senior Director, Medicine Development Leader Full-time Sobi Location: Germany Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them.

The Medicine Development Leader (MDL) has the overall accountability for developing, driving and representing the clinical development strategy for the nephrology program within the Core Asset Team (CAT), including benefit/risk evaluation, pharmacovigilance (PV) and safety.

The MDL leads the Medicine Development Team (MDT) and assures, in close collaboration with the TA head, the appropriate communication flow between the CAT, the MDT and other associated teams (e.g. the Study Team). Is a core member of the benefit risk team (BRT), of regulatory submission teams and of the labeling working group.

Leads in a matrix the clinical scientists and the Medicine Development Team (consists of representatives from Medical Affairs, Clinical Science, Regulatory, Safety/PV, non-clinical/PK, Biostatistics/Data management, Clinical Program Management, Health Economics and Outcome Research, RWE, Program Management), providing strategic guidance and being the ultimate accountable for: Clinical trial design (clinical study synopsis and protocol development), planning (e.g. sites and countries selection), execution (e.g. medical monitoring, resolution of safety issues; interpretation of statistical analyses) and internal and external communication of study results.

Support to registration and market access (Core Data Sheet, Development Safety Update Report, Periodic Safety Update Report, clinical benefit-risk assessment) and collaboration with Regulatory team to determine international submission strategy.

Key Responsibilities Drives the clinical development strategy for the assigned compound(s) across the medicine lifecycle, from proof of concept to successful global regulatory approval(s)/market access for multiple treatment indications. Provides clinical and scientific expertise to set and execute the asset strategy and optimize project success.

Works with functional members, TA head and CAT Leaders to develop Integrated Project Plans (IPP) documents. Identifies risks for the program with other functions and develops mitigation strategies to address them.

Presents the nephrology clinical program to internal (including the CEO and the Executive Committee of the Organisation) and external stakeholders (Health Authorities, Steering Committees, Independent Data Monitoring Committees, and Patient Organisations etc), engages when necessary with Key Opinion Leaders across geographies.

Ensures endorsement of clinical development plans and study documents by Sobi governance bodies (e.g. Sobi Evidence Generation Board, Study Document Review Forum).

Creation of clinical components of key documents (Clinical Development Plans, Clinical Study Protocols, Investigator’s Brochures, Clinical Study Reports, regulatory documents including maintenance of product licenses, Clinical Modules of registration dossiers, Briefing Books for interactions with Health Authorities) with high quality and consistency with the Integrated Project Plan and Target Product Profile.

Provision of required input on clinical efficacy, safety, dosing/administration, mechanism of action, etc., for the Target Product Profile (TPP). Qualifications Medical degree with 10+ years of relevant clinical experience in academic and/or pharmaceutical Global Research